299 related articles for article (PubMed ID: 23649327)
21. Improving drug delivery to solid tumors: priming the tumor microenvironment.
Khawar IA; Kim JH; Kuh HJ
J Control Release; 2015 Mar; 201():78-89. PubMed ID: 25526702
[TBL] [Abstract][Full Text] [Related]
22. Actively targeted nanocarriers for drug delivery to cancer cells.
Biffi S; Voltan R; Bortot B; Zauli G; Secchiero P
Expert Opin Drug Deliv; 2019 May; 16(5):481-496. PubMed ID: 30955393
[TBL] [Abstract][Full Text] [Related]
23. Active targeting strategies for anticancer drug nanocarriers.
Basile L; Pignatello R; Passirani C
Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
25. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
26. Cellulose-based Nanocarriers as Platforms for Cancer Therapy.
Meng LY; Wang B; Ma MG; Zhu JF
Curr Pharm Des; 2017; 23(35):5292-5300. PubMed ID: 29086678
[TBL] [Abstract][Full Text] [Related]
27. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites.
Attia MF; Anton N; Wallyn J; Omran Z; Vandamme TF
J Pharm Pharmacol; 2019 Aug; 71(8):1185-1198. PubMed ID: 31049986
[TBL] [Abstract][Full Text] [Related]
28. Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead.
Akhter MH; Beg S; Tarique M; Malik A; Afaq S; Choudhry H; Hosawi S
Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129777. PubMed ID: 33130062
[TBL] [Abstract][Full Text] [Related]
29. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
30. Transport barriers and strategies of antitumor nanocarriers delivery system.
Zhang L; Wang Y; Cao Y; Lou D; Wang B
J Biomed Mater Res A; 2013 Dec; 101(12):3661-9. PubMed ID: 23983207
[TBL] [Abstract][Full Text] [Related]
31. Nanocarriers in Improving Chemotherapy of Multidrug Resistant Tumors: Key Developments and Perspectives.
Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV
Curr Pharm Des; 2017; 23(22):3301-3308. PubMed ID: 28403792
[TBL] [Abstract][Full Text] [Related]
32. Shaping Tumor Microenvironment for Improving Nanoparticle Delivery.
Gao H
Curr Drug Metab; 2016; 17(8):731-736. PubMed ID: 27396754
[TBL] [Abstract][Full Text] [Related]
33. Editorial: Polymeric Nanocarriers as Robust Platforms for Cancer Therapy.
Elzoghby AO
Curr Pharm Des; 2017; 23(35):5211-5212. PubMed ID: 29110600
[No Abstract] [Full Text] [Related]
34. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
[TBL] [Abstract][Full Text] [Related]
35. Passive and active tumour targeting with nanocarriers.
Hirsjärvi S; Passirani C; Benoit JP
Curr Drug Discov Technol; 2011 Sep; 8(3):188-96. PubMed ID: 21513482
[TBL] [Abstract][Full Text] [Related]
36. Targeting and microenvironment-responsive lipid nanocarrier for the enhancement of tumor cell recognition and therapeutic efficiency.
Gao W; Meng T; Shi N; Zhuang H; Yang Z; Qi X
Adv Healthc Mater; 2015 Apr; 4(5):748-59. PubMed ID: 25522298
[TBL] [Abstract][Full Text] [Related]
37. Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma.
Liu Y; Zhou J; Li Q; Li L; Jia Y; Geng F; Zhou J; Yin T
Adv Drug Deliv Rev; 2021 May; 172():80-103. PubMed ID: 33705874
[TBL] [Abstract][Full Text] [Related]
38. PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer.
Flores O; Santra S; Kaittanis C; Bassiouni R; Khaled AS; Khaled AR; Grimm J; Perez JM
Theranostics; 2017; 7(9):2477-2494. PubMed ID: 28744329
[TBL] [Abstract][Full Text] [Related]
39. Exploring the tumor microenvironment with nanoparticles.
Miao L; Huang L
Cancer Treat Res; 2015; 166():193-226. PubMed ID: 25895870
[TBL] [Abstract][Full Text] [Related]
40. Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer.
Rama AR; Jimenez-Lopez J; Cabeza L; Jimenez-Luna C; Leiva MC; Perazzoli G; Hernandez R; Zafra I; Ortiz R; Melguizo C; Prados J
Curr Drug Deliv; 2016; 13(6):830-8. PubMed ID: 26634791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
